Innovation in medicine: the first patient to receive gene therapy aimed at cell rejuvenation

The American biotechnology company Life Biosciences announced last week that it has administered the first experimental treatment ER-100 to a patient suffering from glaucoma, one of the main causes of blindness.

Informatie preluata din publicatia "Bursa" - citeste integral articolul - click aici